Wan Jingwei, Guo Alyssa Aihui, Chowdhury Indrajit, Guo Shanchun, Hibbert Jacqueline, Wang Guangdi, Liu Mingli
Department of Microbiology, Biochemistry and Immunology, Morehouse School of Medicine, Atlanta, GA, United States.
Department of Neurosurgery, The Second Xiangya Hospital, Central South University, Changsha, China.
Front Oncol. 2019 Dec 17;9:1413. doi: 10.3389/fonc.2019.01413. eCollection 2019.
Our previous findings demonstrate that channel-kinase transient receptor potential (TRP) ion channel subfamily M, member 7 (TRPM7) is critical in regulating human glioma cell migration and invasion. Since microRNAs (miRNAs) participate in complex regulatory networks that may affect almost every cellular and molecular process during glioma formation and progression, we explored the role of miRNAs in human glioma progression by comparing miRNA expression profiles due to differentially expressed TRPM7. First, we performed miRNA microarray analysis to determine TRPM7's miRNA targets upon TRPM7 silencing in A172 cells and validated the miRNA microarray data using A172, U87MG, U373MG, and SNB19 cell lines by stem-loop RT-qPCRs. We next determined whether TRPM7 regulates glioma cell proliferation and migration/invasion through different functional domains by overexpressing wild-type human TRPM7 (wtTRPM7), two mutants with TRPM7's α-kinase domain deleted (Δkinase-DK), or a point mutation in the ATP binding site of the α-kinase domain (K1648R-KR). In addition, we determined the roles of miR-28-5p in glioma cell proliferation and invasion by overexpressing or under expressing miR-28-5p . Lastly, we determined whether a Ras-related small GTP-binding protein (Rap1b) is a target of miR-28-5p in glioma tumorigenesis. The miRNA microarray data revealed a list of 16 downregulated and 10 upregulated miRNAs whose transcripts are significantly changed by TRPM7 knock-down. Cell invasion was significantly reduced in two TRPM7 mutants with inactive kinase domain, Δkinase, and K1648R transfected glioma cells. miR-28-5p overexpression suppressed glioma cells' proliferation and invasion, and miR-28-5p under expression led to a significant increase in glioma cell proliferation and migration/invasion compared to that of the controls. miR-28-5p suppressed glioma cell proliferation and migration by targeting Rap1b. Co-transfection of siRap1b with miR28-5p inhibitor reduced the glioma cell proliferation and invasion, caused by the latter. These results indicate that TRPM7's channel activity is required for glioma cell growth while the kinase domain is required for cell migration/invasion. TRPM7 regulates miR-28-5p expression, which suppresses cell proliferation and invasion in glioma cells by targeting Rap1b signaling.
我们之前的研究结果表明,通道激酶瞬时受体电位(TRP)离子通道M亚家族成员7(TRPM7)在调节人类胶质瘤细胞迁移和侵袭中起关键作用。由于微小RNA(miRNA)参与复杂的调控网络,可能影响胶质瘤形成和进展过程中的几乎每个细胞和分子过程,我们通过比较因TRPM7差异表达而产生的miRNA表达谱,探索了miRNA在人类胶质瘤进展中的作用。首先,我们进行了miRNA微阵列分析,以确定A172细胞中TRPM7沉默后其miRNA靶点,并通过茎环RT-qPCR在A172、U87MG、U373MG和SNB19细胞系中验证miRNA微阵列数据。接下来,我们通过过表达野生型人类TRPM7(wtTRPM7)、两个缺失TRPM7α激酶结构域的突变体(Δ激酶-DK)或α激酶结构域ATP结合位点的点突变(K1648R-KR),来确定TRPM7是否通过不同功能结构域调节胶质瘤细胞增殖和迁移/侵袭。此外,我们通过过表达或下调miR-28-5p来确定miR-28-5p在胶质瘤细胞增殖和侵袭中的作用。最后,我们确定了Ras相关小GTP结合蛋白(Rap1b)是否是miR-28-5p在胶质瘤肿瘤发生中的靶点。miRNA微阵列数据揭示了一份清单,其中16种miRNA下调,10种miRNA上调,其转录本因TRPM7敲低而显著改变。在转染了无活性激酶结构域的两个TRPM7突变体(Δ激酶和K1648R)的胶质瘤细胞中,细胞侵袭显著降低。miR-28-5p过表达抑制胶质瘤细胞增殖和侵袭,与对照组相比,miR-28-5p下调导致胶质瘤细胞增殖和迁移/侵袭显著增加。miR-28-5p通过靶向Rap1b抑制胶质瘤细胞增殖和迁移。将siRap1b与miR28-5p抑制剂共转染可降低后者引起的胶质瘤细胞增殖和侵袭。这些结果表明,TRPM7的通道活性是胶质瘤细胞生长所必需的,而激酶结构域是细胞迁移/侵袭所必需的。TRPM7调节miR-28-5p表达,miR-28-5p通过靶向Rap1b信号抑制胶质瘤细胞增殖和侵袭。